12 Month Price Forecast For DLB
Distance to DLB Price Forecasts
DLB Price Momentum
🤔 Considering Dolby (DLB)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 8, 2025 2:58 AM UTC
DLB Analyst Ratings & Price Targets
Based on our analysis of 8 Wall Street analysts, DLB has a consensus that is bullish. The median price target is $100.00, with forecasts ranging from $100.00 to $100.00. Currently, there are 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With DLB currently trading at $83.86, the median price forecast suggests a 19.2% upside. The most optimistic forecast comes from Patrick Sholl at Barrington Research, projecting a 19.2% upside, while Patrick Sholl at Barrington Research provides the most conservative target, suggesting a 19.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
DLB Analyst Consensus
DLB Price Target Range
Latest DLB Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for DLB.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 30, 2025 | Barrington Research | Patrick Sholl | Outperform | Maintains | $100.00 |
| Jan 30, 2025 | Rosenblatt | Steven Frankel | Buy | Maintains | $100.00 |
| Jan 27, 2025 | Barrington Research | James Goss | Outperform | Maintains | $100.00 |
| Jan 23, 2025 | Rosenblatt | Steven Frankel | Buy | Maintains | $100.00 |
| Nov 20, 2024 | Barrington Research | James Goss | Outperform | Maintains | $100.00 |
| Nov 20, 2024 | Rosenblatt | Steven Frankel | Buy | Maintains | $100.00 |
| Sep 20, 2024 | Barrington Research | James Goss | Outperform | Maintains | $100.00 |
| Aug 9, 2024 | Barrington Research | James Goss | Outperform | Maintains | $100.00 |
| Jun 7, 2024 | Rosenblatt | Steven Frankel | Buy | Maintains | $98.00 |
| Jun 3, 2024 | Barrington Research | James Goss | Outperform | Upgrade | $100.00 |
| May 3, 2024 | Rosenblatt | Steve Frankel | Buy | Maintains | $98.00 |
| Apr 29, 2024 | Rosenblatt | Steve Frankel | Buy | Maintains | $98.00 |
| Jan 31, 2024 | Rosenblatt | Steve Frankel | Buy | Reiterates | $98.00 |
| Dec 11, 2023 | Rosenblatt | Steve Frankel | Buy | Reiterates | $98.00 |
| Nov 17, 2023 | Rosenblatt | Steve Frankel | Buy | Reiterates | $98.00 |
| Aug 4, 2023 | Rosenblatt | Steve Frankel | Buy | Maintains | $98.00 |
| Jul 28, 2023 | Rosenblatt | Steve Frankel | Buy | Reiterates | $93.00 |
| Jun 1, 2023 | Rosenblatt | Steve Frankel | Buy | Reiterates | $93.00 |
| Apr 26, 2023 | Rosenblatt | Steve Frankel | Buy | Reiterates | $90.00 |
| Apr 14, 2023 | Tigress Financial | Ivan Feinseth | Buy | Reiterates | $116.00 |
Stocks Similar to Dolby Laboratories Inc
The following stocks are similar to Dolby based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Dolby Laboratories Inc (DLB) Financial Data
Dolby Laboratories Inc has a market capitalization of $8.13B with a P/E ratio of 31.2x. The company generates $1.26B in trailing twelve-month revenue with a 16.9% profit margin.
Revenue growth is -3.2% quarter-over-quarter, while maintaining an operating margin of +14.1% and return on equity of +8.9%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Dolby Laboratories Inc (DLB) Company Overview
About Dolby Laboratories Inc
Develops audio and imaging technologies for entertainment.
The company generates revenue by developing and licensing advanced audio and imaging technologies, including various digital codecs and hardware for cinema, television, and home entertainment. It sells products directly to end users and distributes through dealers, serving a diverse clientele including film studios, broadcasters, and content creators.
Founded in 1965 and headquartered in San Francisco, Dolby Laboratories is a leader in transforming media experiences across different platforms. Its innovative technologies, such as Dolby Atmos and Dolby Vision, enhance the quality of sound and visuals, making it a key player in the entertainment technology industry.
Company Information
Sector
Industrials
Industry
Specialty Business Services
Employees
2,246
CEO
Mr. Kevin J. Yeaman
Country
United States
IPO Year
2005
Website
www.dolby.comDolby Laboratories Inc (DLB) Latest News & Analysis
Dolby Laboratories, Inc. (NYSE: DLB) will hold its Q1 2025 earnings conference call on January 29, 2024, at 5:00 PM ET, featuring key executives and analysts.
The earnings call will reveal Dolby's Q1 performance, impacting investor sentiment and stock price based on revenue, profitability, and future guidance.
Dolby Laboratories (NYSE: DLB) reported strong financial results for Q1 FY25, according to CEO Kevin Yeaman.
Strong Q1 results from Dolby Laboratories signal robust financial health and potential for growth, influencing investor confidence and stock performance.
Dolby Laboratories (DLB) reported quarterly earnings of $1.14 per share, surpassing the Zacks Consensus Estimate of $1.07, and up from $1.01 per share year-over-year.
Dolby's earnings beat expectations, indicating strong performance and potential growth, which may boost investor confidence and drive stock prices higher.
DLB reported growth in its fiscal Q1 2025, driven by strong performance in the Licensing and Products and Services segments.
DLB's growth in Licensing and Products/services signals strong demand, potentially increasing revenue and profitability, which may boost investor confidence and stock performance.
Dolby Laboratories (DLB) reported its quarterly performance for December 2024, with key metrics available for comparison against Wall Street estimates and previous year results.
Comparing Dolby's latest performance metrics to Wall Street estimates and previous results helps assess growth potential and market expectations, influencing investment decisions.
Dolby Laboratories (DLB) has passed the "Recent Price Strength" screening, indicating potential for investors seeking profitable stocks in active markets.
Dolby's recent price strength suggests growing investor interest, potentially indicating upward momentum and profit opportunities for those considering stock investments.
Frequently Asked Questions About DLB Stock
What is Dolby Laboratories Inc's (DLB) stock forecast for 2025?
Based on our analysis of 8 Wall Street analysts, Dolby Laboratories Inc (DLB) has a median price target of $100.00. The highest price target is $100.00 and the lowest is $100.00.
Is DLB stock a good investment in 2025?
According to current analyst ratings, DLB has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $83.86. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for DLB stock?
Wall Street analysts predict DLB stock could reach $100.00 in the next 12 months. This represents a 19.2% increase from the current price of $83.86. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Dolby Laboratories Inc's business model?
The company generates revenue by developing and licensing advanced audio and imaging technologies, including various digital codecs and hardware for cinema, television, and home entertainment. It sells products directly to end users and distributes through dealers, serving a diverse clientele including film studios, broadcasters, and content creators.
What is the highest forecasted price for DLB Dolby Laboratories Inc?
The highest price target for DLB is $100.00 from Patrick Sholl at Barrington Research, which represents a 19.2% increase from the current price of $83.86.
What is the lowest forecasted price for DLB Dolby Laboratories Inc?
The lowest price target for DLB is $100.00 from Patrick Sholl at Barrington Research, which represents a 19.2% increase from the current price of $83.86.
What is the overall DLB consensus from analysts for Dolby Laboratories Inc?
The overall analyst consensus for DLB is bullish. Out of 8 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $100.00.
How accurate are DLB stock price projections?
Stock price projections, including those for Dolby Laboratories Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
